Open Access
Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World
AKINORI MINATO, RIEKO KIMURO, DAICHI OHNO, KENTAROU TANIGAWA, KEISUKE KURETAKE, TAKUO MATSUKAWA, TOMOHISA TAKABA, KAZUMASA JOJIMA, MIRII HARADA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA, NAOHIRO FUJIMOTO and HIROSHI MIYAMOTO
Anticancer Research September 2023, 43 (9) 4055-4060; DOI: https://doi.org/10.21873/anticanres.16594